PD-L1 expression as a predictive biomarker for cytokine-induced killer cell immunotherapy in patients with hepatocellular carcinoma

Cytokine-induced killer (CIK) cell immunotherapy represents an effective treatment strategy for treating hepatocellular carcinoma (HCC). However, the therapeutic benefits of CIK cell treatment can be influenced by differences in complex immune microenvironment between patients. Herein, we investigat...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Oncoimmunology
Main Authors: Chen, Chang-Long, Pan, Qiu-Zhong, Zhao, Jing-Jing, Wang, Ying, Li, Yong-Qiang, Wang, Qi-Jing, Pan, Ke, Weng, De-Sheng, Jiang, Shan-Shan, Tang, Yan, Zhang, Xiao-Fei, Zhang, Hong-Xia, Zhou, Zi-Qi, Zeng, Yi-Xin, Xia, Jian-Chuan
פורמט: Artigo
שפה:Inglês
יצא לאור: Taylor & Francis 2016
נושאים:
Original Research
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC5006896/
https://ncbi.nlm.nih.gov/pubmed/27622026
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1176653
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים